ICAM1 and neoplasm: These molecules may contribute to, but individually are not sole determinants of, radiotherapy-induced immunogenicity, since some radiation-exposed tumor cells that did not upregulate Fas or possessed defective Fas signaling were still susceptible to CTL-mediated killings [18], whereas blocking ICAM-1 did not abrogate CTL-mediated lysis [50].